Purine derivatives as adenosine A1 receptor agonists and methods of use thereof

Details for Australian Patent Application No. 2005249430 (hide)

Owner Inotek Pharmaceuticals Corporation

Inventors Szabo, Csaba; Salzman, Andrew L.; Jagtap, Prakash

Agent Inotek Pharmaceuticals Corporation

Pub. Number AU-B-2005249430

PCT Pub. Number WO2005/117910

Priority 60/574,805 26.05.04 US; 60/588,263 15.07.04 US

Filing date 25 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 23 June 2011

International Classifications

C07H 19/12 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7076 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117910 Priority application(s): WO2005/117910

23 June 2011 Application Accepted

  Published as AU-B-2005249430

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249434-Cancer treatment method by inhibiting mage gene expression or function

2005249425-Ocular implant and methods for making and using same